These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36882122)

  • 141. Immunosuppressors and reversion of multidrug-resistance.
    Aouali N; Eddabra L; Macadré J; Morjani H
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):61-70. PubMed ID: 15978826
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Insights into the role of glycosyltransferase in the targeted treatment of gastric cancer.
    Wang Y; Zhang P; Luo Z; Huang C
    Biomed Pharmacother; 2024 Sep; 178():117194. PubMed ID: 39137647
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
    Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
    Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
    [TBL] [Abstract][Full Text] [Related]  

  • 144. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target.
    Banford S; Timson DJ
    Curr Cancer Drug Targets; 2017; 17(1):53-61. PubMed ID: 27659430
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation.
    Sanz-Martinez I; Pereira S; Merino P; Corzana F; Hurtado-Guerrero R
    Acc Chem Res; 2023 Mar; 56(5):548-560. PubMed ID: 36815693
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.
    Freire-de-Lima L
    Front Oncol; 2014; 4():59. PubMed ID: 24724053
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Advances in the relationship between glycosyltransferases and multidrug resistance in cancer.
    Wu Y; Chen X; Wang S; Wang S
    Clin Chim Acta; 2019 Aug; 495():417-421. PubMed ID: 31102590
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 149.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 8.